- Section 1 - About the Company
- Gilead Sciences Inc - Key Facts
- Gilead Sciences Inc - Key Employees
- Gilead Sciences Inc - Key Employee Biographies
- Gilead Sciences Inc - Major Products and Services
- Gilead Sciences Inc - History
- Gilead Sciences Inc - Company Statement
- Gilead Sciences Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- Gilead Sciences Inc - Business Description
- Product Category: HIV
- Overview
- Performance
- Product Category: Liver Disease
- Overview
- Performance
- Product Category: Oncology
- Overview
- Performance
- Product Category: Other Products
- Overview
- Performance
- Product Category: Veklury
- Overview
- Performance
- Geographical Segment: Europe
- Performance
- Geographical Segment: Other International
- Performance
- Geographical Segment: U.S.
- Performance
- R&D Overview
- Gilead Sciences Inc - Corporate Strategy
- Gilead Sciences Inc - SWOT Analysis
- SWOT Analysis - Overview
- Gilead Sciences Inc - Strengths
- Gilead Sciences Inc - Weaknesses
- Gilead Sciences Inc - Opportunities
- Gilead Sciences Inc - Threats
- Gilead Sciences Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Gilead Sciences Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Nov 06, 2024: Gilead Sciences Reports Q3 2024 Results
- Oct 22, 2024: Gilead to Present Latest Research Across Key Liver Disease Indication at the American Association for the Study of Liver Disease (AASLD) Meeting 2024
- Oct 09, 2024: Gilead to Present Late-Breaking Data Highlighting Antiviral Portfolio, Innovative Research Pipeline and HIV Leadership at IDWeek 2024
- Oct 09, 2024: Gilead Sciences to Release Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
- Aug 08, 2024: Gilead Sciences Announces Second Quarter 2024 Financial Results
- Jul 25, 2024: MoU signing between HCSA Community Services and Tzu-Chi Foundation (Singapore) to support Hepatitis C elimination initiative for former drug abusers in Singapore
- Jul 25, 2024: Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline
- Jul 25, 2024: Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- Jul 22, 2024: Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia
- Jul 18, 2024: Research Identifies Blind Spots That Affect Quality of Life Among People with HIV in Singapore
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Gilead Sciences Inc, Key Facts
- Gilead Sciences Inc, Key Employees
- Gilead Sciences Inc, Key Employee Biographies
- Gilead Sciences Inc, Major Products and Services
- Gilead Sciences Inc, History
- Gilead Sciences Inc, Other Locations
- Gilead Sciences Inc, Subsidiaries
- Gilead Sciences Inc, Joint Venture
- Gilead Sciences Inc, Key Competitors
- Gilead Sciences Inc, Ratios based on current share price
- Gilead Sciences Inc, Annual Ratios
- Gilead Sciences Inc, Annual Ratios (Cont...1)
- Gilead Sciences Inc, Annual Ratios (Cont...2)
- Gilead Sciences Inc, Interim Ratios
- Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Gilead Sciences Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Gilead Sciences Inc, Performance Chart (2019 - 2023)
- Gilead Sciences Inc, Ratio Charts
- Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook